Toronto Dominion Bank
MRNA icon

Toronto Dominion Bank’s Moderna MRNA Stock Holding History

Toronto Dominion Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Buy
+25,000
New +$1.29M ﹤0.01% 1287
2025
Q1 		– Sell
-56,300
Closed -$2.34M – 1640
2024
Q4 		$2.34M Buy
+56,300
New +$2.69M ﹤0.01% 887

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Toronto Dominion Bank's MRNA Position: Q2 2026 in Review

Toronto Dominion Bank increased its Moderna (MRNA) stake by 14% in Q2 2026, buying an estimated $461K and bringing the position to 70,922 shares worth $4.97M. The position accounts for 0.01% of the portfolio, ranked #937.

Toronto Dominion Bank first reported a position in MRNA in Q2 2020 and has held it in 25 quarters since. The position peaked at $120M in Q3 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Toronto Dominion Bank held 70,922 shares of Moderna worth $4.97M as of Q2 2026.
  • Toronto Dominion Bank bought 8,910 Moderna shares in Q2 2026, an estimated $461K.
  • Moderna made up 0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #937 holding.
  • Toronto Dominion Bank first reported a position in Moderna in Q2 2020 and has held it in 25 quarters since.
  • Toronto Dominion Bank's Moderna position peaked at $120M in Q3 2021.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.